Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170,403,883
-
Total 13F shares
-
30,512,429
-
Share change
-
+1,105,392
-
Total reported value
-
$343,874,136
-
Put/Call ratio
-
30%
-
Price per share
-
$11.27
-
Number of holders
-
78
-
Value change
-
+$13,035,925
-
Number of buys
-
37
-
Number of sells
-
36
Institutional Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q1 2017
As of 31 Mar 2017,
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) was held by
78 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,512,429 shares.
The largest 10 holders included
Flagship Pioneering Inc., FMR LLC, BlackRock Inc., VANGUARD GROUP INC, Capital World Investors, FEDERATED INVESTORS INC /PA/, PRICE T ROWE ASSOCIATES INC /MD/, ARK Investment Management LLC, Artal Group S.A., and D. E. Shaw & Co., Inc..
This page lists
78
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.